Patents by Inventor Johannes Bernhard Prins

Johannes Bernhard Prins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DIFFERENTIATION MODULATING AGENTS AND USES THEREFOR
    Publication number: 20140221455
    Abstract: The present invention is directed to methods and agents for modulating the differentiation potential and/or proliferation of preadipocytes. More particularly, the present invention discloses methods and agents for modulating a fibroblast growth factor (FGF) signaling pathway, especially the FGF-1 or FGF-2 signaling pathway, for treating or preventing adiposity-related conditions including, but not limited to, obesity, lipoma, lipomatosis, cachexia or lipodystrophy or the loss of adipose tissue in trauma or atrophic conditions.
    Type: Application
    Filed: October 7, 2013
    Publication date: August 7, 2014
    Applicant: Verva Pharmaceuticals, Inc.
    Inventors: Johannes Bernhard Prins, Louise Joyce Hutley, Ross Peter McGeary
  • DIFFERENTIATION MODULATING AGENTS AND USES THEREFOR
    Publication number: 20120059047
    Abstract: The present invention is directed to methods and agents for modulating the differentiation potential and/or proliferation of preadipocytes. More particularly, the present invention discloses methods and agents for modulating a fibroblast growth factor (FGF) signaling pathway, especially the FGF-1 or FGF-2 signaling pathway, for treating or preventing adiposity-related conditions including, but not limited to, obesity, lipoma, lipomatosis, cachexia or lipodystrophy or the loss of adipose tissue in trauma or atrophic conditions.
    Type: Application
    Filed: August 29, 2011
    Publication date: March 8, 2012
    Applicant: VERVA PHARMACEUTICALS PTY LTD
    Inventors: Johannes Bernhard Prins, Louise Joyce Hutley, Ross Peter McGeary